Lower than expected mortality with dexamethasone in toxic epidermal necrolysis: 30-year experience of a Northern Mexico reference hospital
- PMID: 31592544
- DOI: 10.1111/ijd.14666
Lower than expected mortality with dexamethasone in toxic epidermal necrolysis: 30-year experience of a Northern Mexico reference hospital
References
-
- Quinn AM, Brown K, Bonish BK, et al. Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis. Arch Dermatol 2005; 141: 683-687.
-
- Zimmermann S, Sekula P, Venhoff M, et al. Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol 2017; 153: 514-522.
-
- Tripathi A, Ditto AM, Grammer LC, et al. Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases. Allergy Asthma Proc 2000; 21: 101-105.
-
- Kimura H, Caturegli P, Takahashi M, et al. New insights into the function of the immunoproteasome in immune and nonimmune cells. J Immunol Res 2015; 2015: 1-8.
Publication types
LinkOut - more resources
Full Text Sources
